Showing results (51-60 of 172) with videos related to
Sort By:
Pageof 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2010
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009R Adam, D G Haller, G Poston, et al.British Journal of Cancer|January 15, 2016
Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancerE Elez, A Hendlisz, T Delaunoit, et al.Forensic Science International|March 25, 2014
Application of hygrine and cuscohygrine as possible markers to distinguish coca chewing from cocaine abuse on WDT and forensic casesN C Rubio, S Strano-Rossi, M J Tabernero, et al.Journal of Pharmaceutical and Biomedical Analysis|July 7, 2018
Determination of benzodiazepines in pericardial fluid by gas chromatography-mass spectrometryI Álvarez-Freire, P Brunetti, P Cabarcos-Fernández, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 19, 2026
From vial to injector: Stability, degradation, and surface interactions of non-derivatized ecgonine methyl ester in GC-MSN C Rubio, I Alvarez-Freire, P Cabarcos-Fernández, et al.ESMO Open|March 19, 2022
Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancersJ Tabernero, F Andre, J-Y Blay, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2018
Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesM Smoragiewicz, J Bogaerts, E Calvo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2013
Genomic aberrations in the FGFR pathway: opportunities for targeted therapies in solid tumorsR Dienstmann, J Rodon, A Prat, et al.Oncogene|April 30, 2013
SPROUTY2 is a β-catenin and FOXO3a target gene indicative of poor prognosis in colon cancerP Ordóñez-Morán, A Irmisch, A Barbáchano, et al.Journal of Applied Toxicology : JAT|March 13, 2012
Hair testing for cocaine and metabolites by GC/MS: criteria to quantitatively assess cocaine useO López-Guarnido, I Álvarez, F Gil, et al.Pageof 18